Long-Term Golimumab Treatment Persistence and Clinical Outcomes in Axial Spondyloarthritis: A Real-World Cohort from Kazakhstan.

Nurgaliyev K, Issayeva B, Soroka N, Sadykova A, Tuleutayeva S, Nurgaliyeva Z, Karibayeva I

Open source

DOI
10.3390/jcm15208099
Published
2026 Oct 19
Container
Journal of clinical medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcm15208099,
  title = {Long-Term Golimumab Treatment Persistence and Clinical Outcomes in Axial Spondyloarthritis: A Real-World Cohort from Kazakhstan.},
  author = {Nurgaliyev K and Issayeva B and Soroka N and Sadykova A and Tuleutayeva S and Nurgaliyeva Z and Karibayeva I},
  year = {2026},
  journal = {Journal of clinical medicine},
  doi = {10.3390/jcm15208099},
  url = {https://doi.org/10.3390/jcm15208099}
}

RIS

TY  - JOUR
TI  - Long-Term Golimumab Treatment Persistence and Clinical Outcomes in Axial Spondyloarthritis: A Real-World Cohort from Kazakhstan.
AU  - Nurgaliyev K
AU  - Issayeva B
AU  - Soroka N
AU  - Sadykova A
AU  - Tuleutayeva S
AU  - Nurgaliyeva Z
AU  - Karibayeva I
PY  - 2026
JO  - Journal of clinical medicine
DO  - 10.3390/jcm15208099
UR  - https://doi.org/10.3390/jcm15208099
ER  - 

APA

K, N., B, I., N, S., A, S., S, T., Z, N., & I, K. (2026). Long-Term Golimumab Treatment Persistence and Clinical Outcomes in Axial Spondyloarthritis: A Real-World Cohort from Kazakhstan.. Journal of clinical medicine. https://doi.org/10.3390/jcm15208099

Source records